Year-end Sale % OFF 
Abstract
Thrombocytopenia is a lesser known but significant complication of heparin therapy. Heparin-dependent, antibody-mediated thrombocytopenia may be accompanied by hemorrhagic or thrombotic sequelae. Thrombosis is more frequent and is associated with significant morbidity and mortality. Diagnostic laboratory findings include a variable reduction in the platelet count during heparin administration and the presence of heparin-dependent platelet-associated antibodies that can induce in vitro platelet aggregation. Discontinuing heparin is the primary treatment, although other therapies may be used. This review discusses clinical features, pathophysiology, laboratory findings, and treatment alternatives.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
